NCT07095517View on ClinicalTrials.gov

Pathways, Risk Factors, and mOleculeS to Prevent Early-onset Colorectal Tumors

PHASE1Not yet recruitingINTERVENTIONAL

Enrollment

20

Participants

Timeline

Start Date

December 1, 2025

Primary Completion Date

August 31, 2026

Study Completion Date

August 31, 2027

Conditions

Colorectal Cancer PreventionColorectal Adenoma

Interventions

DRUG

Tirzepatide

Study drug injected subcutaneously once a week

Trial Locations (1)

02114

Massachusetts General Hospital Cancer Center, Boston

Sponsors

Collaborators (1)

Cancer Research UK

All Listed Sponsors

collaborator

National Cancer Institute (NCI)

NIH

collaborator

Cancer Research UK

OTHER

lead

Massachusetts General Hospital

OTHER